Portrait of Van Halbach
ucsf logo

Van Halbach, MD

Interventional Radiology • Diagnostic Radiology
Portrait of Van Halbach
Portrait of Van Halbach
ucsf logo

Van Halbach, MD

Interventional Radiology • Diagnostic Radiology

On this page

About me

Dr. Van Halbach is a leader in neurointerventional radiology, which uses minimally invasive procedures to diagnose and treat disorders of the brain and spine. He specializes in treating hemorrhagic and ischemic stroke, dural fistulas (abnormal blood vessel connections in the membrane covering the brain and spinal cord) and cerebrovascular malformations (abnormal blood vessels in the brain).

Halbach earned his medical degree at the University of California, Los Angeles. He completed his residency and a fellowship at Ronald Reagan UCLA Medical Center.

Halbach has served as president of the American Society of Interventional and Therapeutic Neuroradiology (now the Society of NeuroInterventional Surgery), and has held numerous other positions in national and international societies. He has coauthored more than 200 peer-reviewed articles. The UCSF Department of Radiology and Biomedical Imaging honored him with its outstanding teaching award in 1999.

Education & training

Board certification

  • Neuroradiology, American Board of Radiology
  • Diagnostic Radiology, American Board of Radiology

Residency

  • Diagnostic Radiology, University of California Los Angeles

Internship

  • Internal Medicine, VA Ambulatory Care Medical Center - Sepulveda

Degree

  • MD, University of California Los Angeles

My expertise

My research

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.